5.3 Acute Gallbladder Disease Treatment with WEGOVY is associated with an increased occurrence of cholelithiasis and cholecystitis
Known associations include hidradenitis suppurativa (HS) and various follicular occlusion syndromes such as pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), pyoderma gangrenosum, acne, hidradenitis suppurativa (PASH), synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO), and pyoderma gangrenosum, acne conglobat, hidradenitis suppurativa, and seronegative spondyloarthritis (PASS)
Injectable long-acting GLP-1s The following long-acting GLP-1 RAs are currently approved for use in the United States in liquid form for subcutaneous (under the skin) injection: Ozempic and Trulicity are injected once per week
Others dress up old diet pill formulations in new packaging
The amount of elemental magnesium differs by formulation
In 2023, Pfizer terminated the clinical development of two oral GLP-1 small molecule agonists, Lotiglipron and Danuglipron